TREACE MEDICAL CONCEPTS, INC. 8-K

What Happened
On May 8, 2026, Treace Medical Concepts, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release that was furnished with the SEC on Form 8-K (Item 2.02). The press release is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: May 8, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: quarter ended March 31, 2026.
• Disclosure: company furnished a press release as Exhibit 99.1 to the Form 8-K.
• The Form 8-K does not itself include the financial line items; the press release contains the detailed quarterly results.

Why It Matters
Quarterly results and related press releases provide the latest information on earnings, revenue, and the company’s financial condition—data investors use to assess short‑term performance and valuation. Treace’s filing indicates the company publicly disclosed its March-quarter results to the market; investors should read the attached press release (Exhibit 99.1) or visit Treace’s investor relations for the specific revenue, profit/loss, and any commentary or guidance.